GAMMA Investing’s Ironwood Pharmaceuticals IRWD Stock Holding History

GAMMA Investing’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11K	Buy	2,774 +392	+16%	+$1.64K	﹤0.01%	3271
2026 Q2	$10K	Sell	2,382 -29	-1%	-$112	﹤0.01%	3201
2026 Q1	$8.46K	Sell	2,411 -51	-2%	-$209	﹤0.01%	3159
2025 Q4	$8.3K	Buy	+2,462	New	+$6.39K	﹤0.01%	3057
2024 Q4	–	Sell	-6,170	Closed	-$25.4K	–	3805
2024 Q3	$25.4K	Sell	6,170 -4,356	-41%	-$23.4K	﹤0.01%	1958
2024 Q2	$68.6K	Buy	10,526 +8,156	+344%	+$57.7K	0.01%	986
2024 Q1	$20.6K	Buy	2,370 +945	+66%	+$11.5K	﹤0.01%	1631
2023 Q4	$20.2K	Buy	+1,425	New	+$14.1K	0.01%	1500

Other funds holding IRWD

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

GAMMA Investing's IRWD Position: Q3 2026 in Review

GAMMA Investing increased its Ironwood Pharmaceuticals (IRWD) stake by 16% in Q3 2026, buying an estimated $1.64K and bringing the position to 2,774 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3271.

GAMMA Investing first reported a position in IRWD in Q4 2023 and has held it in 8 quarters since. The position peaked at $68.6K in Q2 2024. 20 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

GAMMA Investing held 2,774 shares of Ironwood Pharmaceuticals worth $11K as of Q3 2026.
GAMMA Investing bought 392 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $1.64K.
Ironwood Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3271 holding.
GAMMA Investing first reported a position in Ironwood Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
GAMMA Investing's Ironwood Pharmaceuticals position peaked at $68.6K in Q2 2024.
20 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.